Part B: Supplementary Information Sheet (SIS) |
FR Recognition List Number
|
036
|
Date of Entry 07/09/2014
|
FR Recognition Number
|
7-175
|
Standard | |
CLSI C59-A Apoplipoprotein Immunoassays: Development and Recommended Performance Characteristics; Approved Guideline |
|
Scope/AbstractThis guideline describes the characterization and preparation of immunogens, antibodies, samples, and methods, and provides guidance for immunochemical testing of apolipoproteins. |
|
Extent of Recognition
|
Public Law, CFR Citation(s) and Procode(s)*
Regulation Number |
Device Name |
Device Class |
Product Code |
§862.1475 |
Apolipoproteins
|
Class 1
|
MSJ
|
§866.5580 |
Alpha-1-Lipoprotein, Antigen, Antiserum, Control
|
Class 2
|
DER
|
§866.5600 |
Lipoprotein, Low-Density, Antigen, Antiserum, Control
|
Class 2
|
DFC
|
|
Relevant FDA Guidance and/or Supportive Publications*
Appropriate Use of Voluntary Consensus Standards in Premarket Submissions for Medical Devices - Guidance for Industry and Food and Drug Administration Staff, issued September 2018. |
|
FDA Technical Contact
|
Standards Development Organization
|
FDA Specialty Task Group (STG)
|
*These are provided as examples and others may be applicable. |